Cargando…
Triptolide sensitizes cisplatin-resistant human epithelial ovarian cancer by inhibiting the phosphorylation of AKT
Advanced and chemotherapy-resistant ovarian cancer causes high mortality of ovarian cancer, and it is important to find safe and effective drugs to reduce the chemotherapeutic resistance of ovarian cancer. In our study, we attempted to clarify the resistance mechanisms of SKOV3/DDP cells in vitro an...
Autores principales: | Huang, Genhua, Hu, Hui, Zhang, Yao, Zhu, Yinfang, Liu, Junli, Tan, Buzhen, Chen, Tingtao |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Ivyspring International Publisher
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6590046/ https://www.ncbi.nlm.nih.gov/pubmed/31281478 http://dx.doi.org/10.7150/jca.30669 |
Ejemplares similares
-
Anti-cancer and Sensibilisation Effect of Triptolide on Human Epithelial Ovarian Cancer
por: Hu, Hui, et al.
Publicado: (2016) -
Tripterygium glycosides sensitizes cisplatin chemotherapeutic potency by modulating gut microbiota in epithelial ovarian cancer
por: Zhan, Xinlu, et al.
Publicado: (2023) -
GTW inhibits the Epithelial to Mesenchymal Transition of Epithelial Ovarian Cancer via ILK/AKT/GSK3β/Slug Signalling Pathway
por: Feng, Ying, et al.
Publicado: (2021) -
Overexpression of Notch3 and pS6 Is Associated with Poor Prognosis in Human Ovarian Epithelial Cancer
por: Liu, Zhaoxia, et al.
Publicado: (2016) -
Triptolide inhibits JAK2/STAT3 signaling and induces lethal autophagy through ROS generation in cisplatin-resistant SKOV3/DDP ovarian cancer cells
por: Zhong, Yanying, et al.
Publicado: (2021)